- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
So says a proxy filing made after trading on Tuesday, as a couple of suitors included contingent value rights in their bids for the marketer of prostate cancer drug, Xtandi.
There are too many companies in just about every sector of this market, Cramer says.
Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.
Pfizer is making another acquisition.